Literature DB >> 2712834

Human prostatic acid phosphatase: cDNA cloning, gene mapping and protein sequence homology with lysosomal acid phosphatase.

F S Sharief1, H Lee, M M Leuderman, A Lundwall, L L Deaven, C L Lee, S S Li.   

Abstract

The cDNAs encoding human prostatic acid phosphatase were cloned and characterized. The mRNAs contain 3' noncoding regions of heterogeneous sizes 646, 1887 or 1913 nucleotides. A dimer and a monomer of the conserved Alu-repeats are present in the longer 3' noncoding sequences. The complete sequence of 354 amino acids for the mature enzyme was determined by sequencing both cDNA and protein. Human prostatic and lysosomal acid phosphatases exhibit 50% sequence homology, including five Cys residues and two putative N-linked glycosylation sites. The Acp-3 gene coding for human prostatic acid phosphatase was mapped onto chromosome 3 in this investigation. The Acp-2 gene coding for lysosomal acid phosphatase has previously been located on chromosome 11, while the Acp-1 gene coding for red blood cell acid phosphatase is on chromosome 2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712834     DOI: 10.1016/0006-291x(89)91623-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

2.  Comparison of the antigenic peptides between human prostatic and lysosomal acid phosphatases.

Authors:  H S Lee; C L Lee; S S Li
Journal:  J Protein Chem       Date:  1991-04

3.  Tetranucleotide repeat polymorphism at the ACPP locus.

Authors:  S Doak; S Jordan; P McWilliam; P Humphries
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

4.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

5.  Homodimer and heterodimer subunits of human prostate acid phosphatase.

Authors:  H Lee; T M Chu; S S Li; C L Lee
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 6.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18

7.  Identification of gp17 glycoprotein and characterization of prostatic acid phosphatase (PAP) and carboxypeptidase E (CPE) fragments in a human seminal plasma fraction interacting with concanavalin A.

Authors:  A C Marquínez; A M Andreetta; N González; C Wolfenstein-Todel; J M Scacciati de Cerezo
Journal:  J Protein Chem       Date:  2003-07

Review 8.  Human prostatic acid phosphatase: structure, function and regulation.

Authors:  Sakthivel Muniyan; Nagendra K Chaturvedi; Jennifer G Dwyer; Chad A Lagrange; William G Chaney; Ming-Fong Lin
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

9.  Kinetic Studies of Newly Patented Aminoalkanol Derivatives with Potential Anticancer Activity as Competitive Inhibitors of Prostate Acid Phosphatase.

Authors:  Błażej Grodner; Mariola Napiórkowska; Dariusz Maciej Pisklak
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

10.  Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases.

Authors:  Lukasz Huminiecki; Andrew T Lloyd; Kenneth H Wolfe
Journal:  BMC Genomics       Date:  2003-07-29       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.